Search Icon
SideMenu
Home
Blog

Biosimilars Council Press Releases

Blog
  • Blog

October Can Now Afford to do More to Support Her Mental Health
  • Blog

Explosive Growth in Drug Discount Cards is a Symptom of a Broken System
  • Blog

AAM All Access Podcast: Medicare Drug Price Negotiation is Bad for Patients
  • Blog

Drug Price Negotiation Proposals Undermine Current Bipartisan Approaches to Lower Drug Spending
  • Blog

AAM All Access Podcast: CMMB’s Urgent Mission
  • Blog

Proposed BBB Negotiation Framework Discourages Biosimilar Competition, Imposes Higher Costs on Commercially Insured Patients and Their Employers
  • Blog

The Evidence Is Clear: Biosimilar Competition Will Achieve More Savings for Patients Than Build Back Better’s Negotiations
  • Blog

Medicare Negotiations Serve as a Catalyst to a Perpetual Monopolyc
  • Blog

Despite Enrollment In Medicare Prescription Drug Coverage, Over Half of All Seniors Pay Full Cost for Many Generic Drugs
  • Blog

AAM All Access Podcast: Drug Shortages and the U.S. Supply Chain
  • Blog

Everything You Need to Know About Biosimilars – All in One Place
  • Blog

AAM Calls for Federal Trade Commission to Investigate PBM Business Practices
Load More